Category: Side Effect: Eyes / Vision (blindness, retinal detachment, uveitis)
-
Novo Nordisk Semaglutide Drug Ozempic Linked to Vision Loss, Doubling the Risk: December 2024 Update
European Drug Regulators Are Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU…
-
Syfovre Safety Issues Need More Attention Before This Relatively New Eye Drug Gets Widely Prescribed
December 2023 JAMA Ophthalmology Viewpoint Piece About Syfovre Calls for Independent and Unbiased Evaluation (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current challenges with…
-
Apellis Updates Number of Syfovre Retinal Vasculitis Cases But Provides No Further “Explanation”
On That Aspect, in August 2023 Apellis Asked Doctors to Stop Using Syfovre Injection Kits With a 19-gauge Filter Needle (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma…
-
Syfovre Adverse Reaction Cases: Updated Number of Patients With Retinal Vasculitis, Timeline of Events
Additional Information from Apellis and the American Society of Retina Specialists About Ongoing Syfovre Safety Issues (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites…
-
Syfovre Retinal Vasculitis And Severe Intraocular Inflammation Cases Reported By Ophthalmologists
A July 2023 "Dear Doctor" Letter From Apellis Acknowledges This Developing Syfovre Safety Signal Situation (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current…
-
Artificial Tears Vision Loss Case Reports Published in March 2023 Medical Journal
JAMA Ophthalmology Articles Give Details About Serious Eye Infections Due to Use of EzriCare Eye Drops (Posted by Tom Lamb at Drug Injury Watch) Two recent JAMA Ophthalmology medical journal articles presented a detailed EzriCare…
-
February Recalls of Eye Products Due to Bacterial Contamination Causing Serious Infections
Timeline for EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, Delsam Pharma’s Artificial Eye Ointment (Posted by Tom Lamb at Drug Injury Watch) During February 2023 there were recalls of Global Pharma eye products, specifically: EzriCare…
-
Delsam Pharma’s Artificial Eye Ointment Recalled, Weeks After Artificial Tears Products Withdrawal
Updates About Bacterial Contamination Problem for These Over-The-Counter (OTC) Eye Products Given by FDA and CDC (Posted by Tom Lamb at Drug Injury Watch) On February 21, 2023, and February 22, 2023, there were updates…
-
Artificial Tears Eye Drops Recall Involving EzriCare and Delsam Pharma’s Products in February 2023
Serious Infections Causing Vision Loss Have Been Linked to the Use of EzriCare Artificial Tears Lubricant Eye Drops (Posted by Tom Lamb at Drug Injury Watch) Today we pick up where our article from last…
-
EzriCare Artificial Tears Associated With Eye Infections: February 2023 CDC Warnings Issued
CDC Recommends Patients Stop Using EzriCare Artificial Tears Products Pending Additional Guidance For These OTC Eye Drops (Posted by Tom Lamb at Drug Injury Watch) On February 1, 2023, the US Centers for Disease Control…